Shanghai Ovarian Cancer and Family Care Project

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

Ovarian cancer is the most lethal gynaecological malignancy, but its incidence in the general population is low. Due to the lack of effective prevention and successful screening approaches, most cases are diagnosed at advanced stages, leading to poor prognosis. In order to address the research requirements pertaining to ovarian cancer, the Shanghai Ovarian Cancer and Family Care Project was established. This initiative offers hospital-based resources for investigating ovarian cancer and high-risk populations. The project comprises an on-going ovarian cancer cohort, a high-risk population cohort, and a healthy population cohort. By leveraging these comprehensive cohorts, the project provides a unique platform for in-depth studies on the detection, prevention, early diagnosis, treatment, and prognosis of ovarian cancer.

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Healthy Volunteers: t
View:

⁃ Participant meet the criteria for one of the following conditions:

• Patients attending the oncology department require differential diagnosis of ovarian cancer.

• Patients with known high-risk factors for ovarian cancer, such as history of ovarian cancer or BRCA-associated cancer, etc.

• Patients attending the Physical Examination Center who have normal findings on physical examination and no symptoms.

Locations
Other Locations
China
Shanghai first maternity and infant hospital
RECRUITING
Shanghai
Contact Information
Primary
Yu Wang, MD; PhD
renjiwangyu@126.com
20261208
Time Frame
Start Date: 2013-01-01
Estimated Completion Date: 2028-10-13
Participants
Target number of participants: 3546
Treatments
Ambispective patient cohort
Patients attending the oncology department require differential diagnosis of ovarian cancer.
High-risk population cohort
Family members of ovarian cancer patients; family history of BRCA mutation-related disease; abnormal findings on ovarian cancer screening; history of ovarian disease and other risk factors.
Healthy control cohort
Healthy women with normal health examination results.
Related Therapeutic Areas
Sponsors
Leads: Shanghai First Maternity and Infant Hospital

This content was sourced from clinicaltrials.gov